Complications of Age-Related Macular Degeneration Prevention Trial

PHASE3CompletedINTERVENTIONAL
Enrollment

1,052

Participants

Timeline

Start Date

May 31, 1999

Study Completion Date

June 30, 2006

Conditions
Macular Degeneration
Interventions
PROCEDURE

Low-Intensity Laser Treatment

Initial: 60 barely visible burns, grid pattern. Re-treatment at 12 months: 30 barely visible burns, focal treatment.

Trial Locations (24)

19104

Scheie Eye Institute, Philadelphia

28204

Southeast Clinical Research Associates, Charlotte

30322

Emory Eye Center, Atlanta

43210

The Ohio State University, Department of Ophthalmology, Columbus

44122

Retina Associates of Cleveland, Cleveland

48073

Associate Retinal Consultants, P.C., Royal Oak

53705

University of Wisconsin - Madison, Department of Ophthalmology and Visual Sciences, Madison

55905

Mayo Clinic, Rochester

60426

Illinois Retina Associates, S.C., Harvey

60611

Northwestern University, Chicago

63110

Barnes Retina Institute, St Louis

75231

Texas Retina Associates, Dallas

85201

Retinal Consultants of Arizona, Ltd., Mesa

85351

Retinal Consultants of Arizona, Ltd., Peoria

94107

West Coast Retina Medical Group, Inc., San Francisco

97210

Retina Northwest, P.C., Portland

33612-4766

University of South Florida Eye Institute, Tampa

55242-1091

University of Iowa, Iowa City

40202-1594

Ophthalmology & Visual Sciences at the University of Louisville, School of Medicine, Louisville

21287-9223

The Johns Hopkins University, Baltimore

02114

Ophthalmic Consultants of Boston, Boston

08820

Retina-Vitreous Center, P.A., Edison

08701

Retina-Vitreous Center, P.A., Lakewood

97201-4197

Casey Eye Institute, Portland

All Listed Sponsors
lead

National Eye Institute (NEI)

NIH